GO
Loading...

Life Sciences

More

  • WINNIPEG, Manitoba, Aug 25- Four monkeys survived the Ebola virus after being injected with a vaccine that included Immunovaccine Inc's technology, the tiny Canadian company said on Monday, and the announcement sent its stock soaring.

  • NEW YORK, Aug 20- An experimental drug from Tekmira Pharmaceuticals Corp helped lab monkeys recover from the most deadly strain of Marburg virus, a close cousin of Ebola, even after symptoms appeared, scientists reported on Wednesday.

  • LOS ANGELES, Aug 17- Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies.

  • *Liberia to treat infected doctors with trial drug ZMapp. LONDON/ GENEVA, Aug 12- People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organisation said on Tuesday, but the scarcity of supplies has raised questions about who gets priority access to treatment.

  • *Liberia to treat infected doctors with trial drug ZMapp. LONDON/ GENEVA, Aug 12- People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organisation said on Tuesday, but the scarcity of supplies raises questions about who gets priority access to treatment.

  • LONDON, Aug 12- World Health Organization experts fighting the world's worst outbreak of Ebola hope for improved supplies of experimental treatments and progress with a vaccine by the end of the year.

  • The Ebola epidemic in West Africa has killed nearly 1,000 people and prompted the World Health Organization to declare an international health emergency. GSK is co-developing a vaccine with the U.S. National Institute of Allergy and Infectious Diseases, which has shown promising results in primates.

  • U.S. biotech firm Celladon hopes that its Mydicar treatment can help patients like Lee Adams who have advanced heart failure and rely on so called Left Ventricular Assist Devices to keep them alive until a donor heart becomes available.

  • Clinical trial to start soon on GSK Ebola vaccine Sunday, 10 Aug 2014 | 11:33 AM ET

    LONDON, Aug 10- A clinical trial of an experimental vaccine against the deadly Ebola virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with U.S. scientists.

  • Medical marijuana research hits wall of US law Sunday, 10 Aug 2014 | 7:54 AM ET
    A man purchases medical marijuana, the first legal sale, at Capital City Care in Washington, DC. The District of Columbia city council is to vote on decriminalizing pot.

    U.S. scientists face legal obstacles and frustrations in trying to study the medical uses of marijuana, the New York Times reports.

  • The World Health Organization has declared the West African epidemic a public health emergency, reviving interest in antiviral drugs that could treat Ebola. Companies such as Tekmira Pharmaceutical Corp, BioCryst Pharmaceuticals Inc and NanoViricides Inc have drugs that are still in pre-clinical trials, meaning they are yet to be tested in humans.

  • NEW YORK, Aug 6- Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.

  • The drug, developed by Mapp Biopharmaceutical Inc, was used to treat two workers from the Samaritan's Purse group who were exposed to the disease in Liberia, according to a U.S. government health official. The official said the treatment was administered in Liberia.

  • LONDON, July 24- GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa.

  • UPDATE 2-Gambro acquisition boosts Baxter's sales Thursday, 17 Jul 2014 | 1:30 PM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

  • Sanofi dengue vaccine promising but questions remain Thursday, 10 Jul 2014 | 7:01 PM ET

    PARIS, July 11- The first vaccine against dengue fever, from France's Sanofi, provided moderate protection in a large clinical study, but questions remain as to how well it can help fight the world's fastest-growing tropical disease.

  • French biotechs court U.S. investors amid wave of IPOs Wednesday, 25 Jun 2014 | 8:07 AM ET

    PARIS, June 25- Eighteen French biotech firms, several newly listed on the Paris stock market, head to New York on Wednesday and Thursday to convince U.S. investors to help fund the next stages of their research and development.

  • June 24- A late-stage trial testing Bristol-Myers Squibb Co's cancer immunotherapy nivolumab in advanced melanoma patients was halted early after it was determined that the drug was likely to prolong survival, the company said on Tuesday.

  • WASHINGTON, June 24- A GlaxoSmithKline Plc plant in Canada that makes the flu vaccine Flulaval has been cited by the U.S. Food and Drug Administration for failing to meet quality control standards.

  • June 18- U.S. drugmaker Pfizer, which failed last month in a $118 billion bid to buy AstraZeneca, said on Wednesday it had signed a deal with French biotech Cellectis to develop immunotherapy drugs in cancer. Under the new deal, Cellectis will receive an upfront payment of $80 million, as well as funding for research costs.